trending Market Intelligence /marketintelligence/en/news-insights/trending/9ep_wklibgofynexxrxrpa2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Inspyr Therapeutics' chief medical officer, directors resign

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Inspyr Therapeutics' chief medical officer, directors resign

Inspyr Therapeutics, Inc. said chief medical officer Ronald Shazer resigned from his position, effective Feb. 12.

Directors Peter Grebow and Richard Buller resigned from the company's board, effective Feb. 9.

The board resignations did not result from any disagreement with the company or matter relating to its operations, policies or practices, the Westlake Village, Calif.-based drug developer said in a Feb. 14 filing with the SEC.